Filing Details

Accession Number:
0001140361-12-010934
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-24 20:29:46
Reporting Period:
2012-02-23
Filing Date:
2012-02-24
Accepted Time:
2012-02-24 20:29:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
69499 Mylan Inc. MYL Pharmaceutical Preparations (2834) 251211621
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1113186 J Douglas Leech 1500 Corporate Drive
Canonsburg PA 15317
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-23 16,875 $14.12 48,027 No 4 M Direct
Common Stock Disposition 2012-02-23 16,875 $23.36 31,152 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Right to Buy Acquisiton 2012-02-23 16,875 $0.00 16,875 $14.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,875 2003-06-20 2012-06-20 No 4 M Direct
Footnotes
  1. As disclosed in the Company's Form 10-Q for the quarter ended September 30, 2011, Ms. Leech's stock options were among those held by directors that were set to expire in 2012.